The placebo response in medicine: minimize, maximize or personalize?
The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Abstract
Our understanding of the mechanisms mediating or moderating the placebo response to medicines has grown substantially over the past decade and offers the opportunity to capitalize on its benefits in future drug development as well as in clinical practice. In this article, we discuss three strategies that could be used to modulate the placebo response, depending on which stage of the drug development process they are applied. In clinical trials the placebo effect should be minimized to optimize drug-placebo differences, thus ensuring that the efficacy of the investigational drug can be truly evaluated. Once the drug is approved and in clinical use, placebo effects should be maximized by harnessing patients' expectations and learning mechanisms to improve treatment outcomes. Finally, personalizing placebo responses - which involves considering an individual's genetic predisposition, personality, past medical history and treatment experience - could also maximize therapeutic outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This might be due to patients' expectations of benefits in clinical trials with novel substances, behavioral conditioning in research settings, or the striking overlap in neuroanatomical substrates between affected brain regions in MDD and placebo response [161]”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [161]
Citations
Cites
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
Moseley, J. B., O'Malley, K., Petersen, N. J., Menke, T. J., Brody, B. A., Kuykendall, D. H., Hollingsworth, J. C., Ashton, C. M., & Wray, N. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013259 · Cited by 2,149
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196
THE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077
A New Design for Randomized Clinical Trials
Zelen, M. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905313002203 · Cited by 1,055
Behaviorally Conditioned Immunosuppression
Ader, R., & Cohen, N. (1975) · Psychosomatic Medicine · doi:10.1097/00006842-197507000-00007 · Cited by 1,018
Research works printed but not linked: 1
- Kaptchuk, T. J. et al. Do “placebo responders” exist? Contemp. Clin. Trials. 29, 587–595 (2008). · DOI
Cited by
Items 101–200 of 674
Murray, D., & Stoessl, A. J. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.009 · Cited by 83
Lindheimer, J. B., Szabo, A., Raglin, J. S., & Beedie, C. (2020) · European Journal of Sport Science · doi:10.1080/17461391.2019.1632937 · Cited by 64
The placebo-nocebo response: controversies and challenges from clinical and research perspective
Jakovljevic, M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.014 · Cited by 63
Maximizing treatment efficacy through patient stratification in neuropathic pain trials
Baron, R., Dickenson, A. H., Calvo, M., Dib‐Hajj, S. D., & Bennett, D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00741-7 · Cited by 72
Placebo and nocebo effect: a mini-review.
Požgain, I., Požgain, Z., & Degmečić, D. (2014) · PubMed · Cited by 102
Hoekman, D. R., Zeevenhooven, J., van Etten‐Jamaludin, F. S., Dekker, I. D., Benninga, M. A., Tabbers, M. M., & Vlieger, A. M. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.12.022 · Cited by 70
Klinger, R., Kothe, R., Schmitz, J., Kamping, S., & Flor, H. (2017) · Pain · doi:10.1097/j.pain.0000000000000977 · Cited by 69
Prognosis and Improved Outcomes in Major Depression: A Review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2020) · Focus · doi:10.1176/appi.focus.18205 · Cited by 62
Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders
Enck, P., & Klosterhalfen, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00797 · Cited by 65
“Eliminating placebo-controlled studies and replacing them with comparator trials (also called head-to-head trials) do not eliminate the placebo effect but make it more difficult to identify and quantify it—placebo effects are immanent to all medical and psychological therapeutic interventions and may also affect diagn…”
BackgroundSelf-citationPlacebo effects and racial and ethnic health disparities: an unjust and underexplored connection
Friesen, P., & Blease, C. R. (2018) · Journal of Medical Ethics · doi:10.1136/medethics-2018-104811 · Cited by 66
Leung, Y. Y., Haaland, B., Huebner, J. L., Wong, S. B.-S., Tjai, M., Wang, C., Chowbay, B., Thumboo, J., Chakraborty, B., Tan, M. H., et al. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.01.026 · Cited by 69
Placebo effects in osteoarthritis: implications for treatment and drug development
Neogi, T., & Colloca, L. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01021-4 · Cited by 64
Go open: A plea for transparency in psychotherapy.
Gaab, J., Blease, C., Locher, C., & Gerger, H. (2016) · Psychology of Consciousness: Theory, Research, and Practice · doi:10.1037/cns0000063 · Cited by 60
Efficacy and placebo response of repetitive transcranial magnetic stimulation for primary insomnia
Jiang, B., He, D., Guo, Z., Mu, Q., & Zhang, L. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.05.008 · Cited by 62
Cannabis in Parkinson’s Disease: The Patients’ View
Yenilmez, F., Fründt, O., Hidding, U., & Buhmann, C. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202260 · Cited by 59
“However, cannabis intake might be related to a relevant placebo effect because of high patient expectations and conditioning buteventhanitcanbeconsideredastherapeuticeffect [13].”
Placebos and the Placebo Effect in Drug Trials
Enck, P., & Klosterhalfen, S. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_269 · Cited by 68
Self-citationRandomised placebo-controlled trials of surgery: ethical analysis and guidelines
Savulescu, J., Wartolowska, K. A., & Carr, A. (2016) · Journal of Medical Ethics · doi:10.1136/medethics-2015-103333 · Cited by 64
Κube, T., & Rief, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.022 · Cited by 61
Self-citationPlacebo effects in allergen immunotherapy—An EAACI Task Force Position Paper
Pfaar, O., Agache, I. O., Bergmann, K., Bindslev‐Jensen, C., Bousquet, J. J., Creticos, P. S., Devillier, P., Durham, S. R., Hellings, P. W., Kaul, S., et al. (2020) · Allergy · doi:10.1111/all.14331 · Cited by 61
Self-citationHorne, R., Chan, A. H. Y., & Wileman, V. (2018) · Routledge eBooks · doi:10.4324/9781315167534-11 · Cited by 59
Nickel, M. M., Tiemann, L., Hohn, V. D., May, E. S., Ávila, C. G., Eippert, F., & Ploner, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116616119 · Cited by 65
“For instance, expectations of pain relief during placebo manipulations can yield substantial and clinically highly relevant decreases of pain (Finniss et al., 2010; Enck et al., 2013; Wager and Atlas, 2015).”
BackgroundPreserving Learned Immunosuppressive Placebo Response: Perspectives for Clinical Application
Albring, A., Wendt, L., Benson, S., Nissen, S., Yavuz, Z., Engler, H., Witzke, O., & Schedlowski, M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.75 · Cited by 53
Self-citationThe placebo effect in allergen‐specific immunotherapy trials
Narkus, A., Lehnigk, U., Häfner, D., Klinger, R., Pfaar, O., & Worm, M. (2013) · Clinical and Translational Allergy · doi:10.1186/2045-7022-3-42 · Cited by 58
“Currently, the placebo effect is discussed in matters of clinical relevance [15].”
BackgroundNocebo vs. Placebo: The Challenges of Trial Design in Analgesia Research
Vase, L., Amanzio, M., & Price, D. D. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.31 · Cited by 59
Placebo, nocebo, and neuropathic pain
Vase, L., Skyt, I., & Hall, K. T. (2015) · Pain · doi:10.1097/j.pain.0000000000000445 · Cited by 63
Frisaldi, E., Shaibani, A. I., Benedetti, F., & Pagnini, F. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-077243 · Cited by 58
“113 Our considerations for better future trial design were outlined as well, which do not include the current strategy to artificially reduce placebo responses.”
BackgroundHindryckx, P., Levesque, B. G., Holvoet, T., Durand, S., Tang, C., Parker, C. E., Khanna, R., Shackelton, L. M., D’Haens, G., Sandborn, W. J., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312762 · Cited by 55
Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
Shah, E. D., & Pimentel, M. (2014) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2014.20.2.163 · Cited by 57
“bo therapy generally carries a negative implication in clinical trials against which drug response must be corrected.(1,2) The placebo response rate in clinical trials against endpoints designed to evaluate investigational drugs in IBS is remarkable at 37.”
BackgroundKeitel, A., Wojtecki, L., Hirschmann, J. V., Hartmann, C. J., Ferrea, S., Südmeyer, M., & Schnitzler, A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.051 · Cited by 53
Mothes, H., Leukel, C., Jo, H., Seelig, H., Schmidt, S., & Fuchs, R. (2016) · Journal of Behavioral Medicine · doi:10.1007/s10865-016-9781-3 · Cited by 56
Rheker, J., Winkler, A., Doering, B. K., & Rief, W. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4466-8 · Cited by 49
“Although some authors differentiate between expectations and conditioning as different mechanisms involved in placebo and nocebo responses (Enck et al. 2013), it is not alwayspossible to clearly distinguish themsince learning also leads to certain expectations (Stewart-Williams and Podd 2004).”
BackgroundSelf-citationJairath, V., Zou, G., Parker, C. E., MacDonald, J. K., Mosli, M. H., AlAmeel, T., Beshir, M. A., Almadi, M. A., Al-Taweel, T., Atkinson, N. S. S., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13973 · Cited by 53
“In clinical practice, maximising placebo effects is desirable when treating patients with established therapies.(2) However, in drug development, minimising placebo effects is essential to efficiently detect true differences between an active treatment and placebo.”
Meister, R., Abbas, M., Antel, J., Peters, T., Pan, Y., Bingel, U., Nestoriuc, Y., & Hebebrand, J. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1244-7 · Cited by 55
Self-citationJairath, V., Zou, G., Parker, C. E., MacDonald, J. K., Mosli, M. H., Khanna, R., Shackelton, L. M., Vandervoort, M. K., AlAmeel, T., Beshir, M. A., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw004 · Cited by 50
“Eligible studies were RCTs fulfilling the following criteria: [1] a placebo-controlled trial in adult patients with UC of either a biological agent, corticosteroid, immunosuppressant, or aminosalicylate; [2] use of the Disease Activity Index 6 or the nearly identical Mayo [or modified Mayo] Clinic Score 7,8 as enrolme…”
MethodRoderigo, T., Benson, S., Schöls, M., Hetkamp, M., Schedlowski, M., Enck, P., & Elsenbruch, S. (2017) · Pain · doi:10.1097/j.pain.0000000000000940 · Cited by 47
“Hence, it is a challenging yet indispensable future research task to elucidate mediators and moderators of placebo and nocebo responses in patients experiencing symptoms of urgency and/or visceral pain to delineate the putative role of stress and expectations in treatment response in everyday clinical practice as well…”
Self-citationBrihi, J. E., Horne, R., & Faasse, K. (2018) · Annals of Behavioral Medicine · doi:10.1093/abm/kay011 · Cited by 57
Unsolved, Forgotten, and Ignored Features of the Placebo Response in Medicine
Enck, P., Klosterhalfen, S., & Weimer, K. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.11.016 · Cited by 53
Self-citationBenedetti, F., Frisaldi, E., & Shaibani, A. I. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052120-104536 · Cited by 60
Wilhelm, M., Rief, W., & Doering, B. K. (2018) · International Journal of Behavioral Medicine · doi:10.1007/s12529-018-9726-z · Cited by 55
Self-citationTrivedi, M. H., South, C. C., Jha, M. K., Rush, A. J., Cao, J., Kurian, B. T., Phillips, M. L., Pizzagalli, D. A., Trombello, J. M., Oquendo, M. A., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491093 · Cited by 50
Wendt, L., Albring, A., Benson, S., Engler, H., Engler, A., Hinney, A., Rief, W., Witzke, O., & Schedlowski, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107665 · Cited by 47
Self-citationWartolowska, K. A., Feakins, B. G., Collins, P. G. S., Cook, J. A., Judge, A., Rombach, I., Dean, B. J. F., Smith, J., & Carr, A. J. (2016) · Trials · doi:10.1186/s13063-016-1720-7 · Cited by 48
“Therefore, in these instances, the “additive model” may not be valid [47].”
BackgroundReevaluating the Placebo Effect in Medical Practice
Colloca, L., Jonas, W. B., Killen, J., Miller, F. G., & Shurtleff, D. (2014) · Zeitschrift für Psychologie · doi:10.1027/2151-2604/a000177 · Cited by 46
“Recent research involving clinical investigations and state-of-the-art neuroimaging techniques has unearthed a number of important findings regarding mechanisms of placebo effects that are not necessarily related to the administration of any placebos (Colloca et al., 2004; Enck et al., 2013).”
BackgroundBishop, F. L., Coghlan, B., Geraghty, A. W., Everitt, H., Little, P., Holmes, M. M., Seretis, D., & Lewith, G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015516 · Cited by 46
Placebo Effects in the Immune System
Hadamitzky, M., Sondermann, W., Benson, S., & Schedlowski, M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.01.001 · Cited by 60
Self-citationHuneke, N. T. M., Amin, J., Baldwin, D. S., Bellato, A., Brandt, V. C., Chamberlain, S. R., Correll, C. U., Eudave, L., Garner, M. J., Gosling, C. J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02638-x · Cited by 47
“Consequently, the trial ’ s ability to statistically differentiate between an active medication and a placebo is diminished [40].”
Long-Term Treatment with High-Dose Thiamine in Parkinson Disease: An Open-Label Pilot Study
Costantini, A., Pala, M. I., Grossi, E., Mondonico, S., Cardelli, L. E., Jenner, C., Proietti, S., Colangeli, M., & Fancellu, R. (2015) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2014.0353 · Cited by 45
“Although placebo interventions in PD may have immediate subjective improvement but no significant objective motor changes compared with levodopa,(31) and although clinical improvement of our patients has been continuous and stable for a long period of follow-up (>2 years), the lack of a placebo group makes these resul…”
Placebo Effects and the Ethics of Therapeutic Communication: A Pragmatic Perspective
Annoni, M., & Miller, F. G. (2016) · Kennedy Institute of Ethics journal · doi:10.1353/ken.2016.0004 · Cited by 57
“Importantly, these are all conditions that are known to be amenable to placebo modulation (Bendetti 2009; Enck et al. 2013).”
BackgroundHow can placebo effects best be applied in clinical practice? A narrative review
Bystad, M. K., Wynn, R., & Bystad, C. (2015) · Psychology Research and Behavior Management · doi:10.2147/prbm.s75670 · Cited by 48
Deceptive and Nondeceptive Placebos to Reduce Pain: An Experimental Study in Healthy Individuals
Κube, T., Rief, W., Vivell, M.-B., Schäfer, N. L., Vermillion, T., Körfer, K., & Glombiewski, J. A. (2019) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000781 · Cited by 50
Self-citationPlacebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis
Curie, A., Yang, K., Kirsch, I., Gollub, R. L., des Portes, V., Kaptchuk, T. J., & Jensen, K. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133316 · Cited by 43
“This is noteworthy, as the investigation of placebo responses in patients with ID may (i) elucidate the impact of the “provision of care” independent of active medication [6], (ii) revise accepted theories of placebo mechanisms that focus on learning and higher order cognition [4, 7, 8], and (iii) improve the way clin…”
BackgroundThe effect of transcranial direct current stimulation on experimentally induced heat pain
Aslaksen, P. M., Vasylenko, O., & Fagerlund, A. J. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-3878-0 · Cited by 43
Network analysis of the genomic basis of the placebo effect
Wang, R., Hall, K. T., Giulianini, F., Passow, D., Kaptchuk, T. J., & Loscalzo, J. (2017) · JCI Insight · doi:10.1172/jci.insight.93911 · Cited by 45
“Detailed knowledge of the placebome will help us understand how genomics might influence the role of the placebo in patient care and clinical research, and eventually allow researchers to tailor treatments to individuals and more efficiently disentangle drug effects from placebo effects (3).”
BackgroundWeihs, K. L., Murphy, W., Abbas, R., Chiles, D., England, R. D., Ramaker, S., & Wajsbrot, D. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0100 · Cited by 52
“Recent thinking about placebo response as ubiquitous in clinical medicine has led to additional recommendations, including systematic measuring and statistical control for nonpharmacological patient factors and therapeutic alliance, separation of recruitment from trial conductance to reduce selection bias by the clini…”
BackgroundPalese, A., Rossettini, G., Colloca, L., & Testa, M. (2019) · PAIN Reports · doi:10.1097/pr9.0000000000000716 · Cited by 56
“Positive contextual factors can increase the effectiveness of the intervention, whereas negative contextual factors can decrease it.(47) As a consequence, contextual factors embody an unavoidable component of nursing care responsible of influencing the overall patients’ outcomes,(83) such as (1) the positive patient’s…”
BackgroundSchmitz, J., Müller, M., Stork, J., Eichler, I., Zöllner, C., Flor, H., & Klinger, R. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000501385 · Cited by 45
Treatment history and placebo responses to experimental and clinical pain in chronic pain patients
Müller, M., Kamping, S., Benrath, J., Skowronek, H., Schmitz, J., Klinger, R., & Flor, H. (2016) · European Journal of Pain · doi:10.1002/ejp.877 · Cited by 51
“The placebo response is defined as a person’s improvement in symptoms following the application of a placebo (Enck et al., 2013).”
BackgroundInfluentialKleine‐Borgmann, J., Schmidt, K., Billinger, M., Forkmann, K., Wiech, K., & Bingel, U. (2021) · Scientific Reports · doi:10.1038/s41598-021-81502-2 · Cited by 42
Self-citationJairath, V., Zou, G., Parker, C. E., MacDonald, J. K., AlAmeel, T., Beshir, M. A., Almadi, M. A., Al-Taweel, T., Atkinson, N. S. S., Biswas, S., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011572.pub2 · Cited by 45
Bulaj, G. W., Ahern, M., Kuhn, A. K., Judkins, Z., Bowen, R. C., & Chen, Y. (2016) · Current Clinical Pharmacology · doi:10.2174/1574884711666160603012237 · Cited by 44
“Optimal design of randomized and placebo-controlled clinical trials for any new therapy is critical for demonstrating its efficacy [291].”
BackgroundKöteles, F., & Doering, B. K. (2016) · Journal of Health Psychology · doi:10.1177/1359105315588216 · Cited by 39
“Nocebo phenomena are negative responses to inert treatments, such as the occurrence of side effects in the placebo-arm of a randomized clinical drug trial (Enck et al., 2013).”
BackgroundZhou, L., Wei, H., Zhang, H., Li, X., Bo, C., Wan, L., Lu, X., & Hu, L. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00020 · Cited by 45
“In terms of the second aspect of response expectancy, previous studies have demonstrated that individual belief in the current experience has a critical influence on response expectancy through learning mechanisms (21, 24).”
BackgroundResultAcupuncture for the Treatment of Pain – A Mega-Placebo?
Musial, F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01110 · Cited by 50
Keitel, A., Ferrea, S., Südmeyer, M., Schnitzler, A., & Wojtecki, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081878 · Cited by 43
“Thus, the identification of potential psychological, neuroendocrine and genetic factors that might play a role in mediating responsiveness and responses, respectively, is a matter of current debate and investigation in placebo and nocebo research (for a review see [14]).”
BackgroundA new animal model of placebo analgesia: involvement of the dopaminergic system in reward learning
Lee, I., Lee, B., Park, H., Olausson, H., Enck, P., & Chae, Y. (2015) · Scientific Reports · doi:10.1038/srep17140 · Cited by 44
Self-citationMa, C., Panaccione, N., Nguyen, T. M., Guizzetti, L., Parker, C. E., Hussein, I. M., Casteele, N. V., Khanna, R., Dulai, P. S., Singh, S., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz087 · Cited by 41
Stub, T., Kristoffersen, A. E., Alræk, T., Musial, F., & Steinsbekk, A. (2015) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2015.06.004 · Cited by 47
“This practice can lead to a nocebo effect (42).”
BackgroundExpectation-Focused Psychotherapy to Improve Clinical Outcomes
Doering, B. K., Glombiewski, J. A., & Rief, W. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.02.004 · Cited by 43
Self-citationFava, G. A. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000520251 · Cited by 46
How do they add up? The interaction between the placebo and treatment effect: A systematic review
Boussageon, R., Howick, J., Baron, R., Naudet, F., Falissard, B., Harika‐Germaneau, G., Wassouf, I., Gueyffier, F., Jaafari, N., & Blanchard, C. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15345 · Cited by 36
“In the case of antagonistic interaction, the total effect of a treatment is inferior to the sum total of the placebo effect and the specific effect of the treatment, whereas in the synergistic model the total effect of a treatment is superior to the sum total of the placebo effect and the specific effect.(6,12,18) In…”
BackgroundNocebo Effects: Neurobiological Mechanisms and Strategies for Prevention and Optimizing Treatment
Kleine‐Borgmann, J., & Bingel, U. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.02.005 · Cited by 39
Self-citationCognitive Factors Mediate Placebo Responses in Patients with House Dust Mite Allergy
Vits, S., Cesko, E., Benson, S., Rueckert, A., Hillen, U., Schadendorf, D., & Schedlowski, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079576 · Cited by 35
“The knowledge about the underlying neuropsychological mechanisms mediating the anti-allergic placebo responses is essential not only for better controlling the placebo response in clinical trials [11].”
BackgroundSelf-citationPlacebo-Induced Somatic Sensations: A Multi-Modal Study of Three Different Placebo Interventions
Beißner, F., Brünner, F., Fink, M., Meißner, K., Kaptchuk, T. J., & Napadow, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124808 · Cited by 38
“Recent studies have also delineated a neurobiological substrate for placebo effects [2,3].”
BackgroundBott, F. S., Nickel, M. M., Hohn, V. D., May, E. S., Ávila, C. G., Tiemann, L., Groß, J., & Ploner, M. (2023) · Science Advances · doi:10.1126/sciadv.add7572 · Cited by 38
“Expectations can yield powerful and clinically relevant changes of the pain experience, for example, through placebo and nocebo effects ( 4 – 7 ).”
Theysohn, N., Schmid, J., Icenhour, A., Mewes, C., Forsting, M., Gizewski, E. R., Schedlowski, M., Elsenbruch, S., & Benson, S. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12454 · Cited by 37
Self-citationAn Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review
Hariprasad, S. M., Gale, R. P., Weng, C. Y., Ebbers, H. C., Rezk, M. F., & Tadayoni, R. (2022) · Ophthalmology and Therapy · doi:10.1007/s40123-022-00488-w · Cited by 35
Memory-updating abrogates extinction of learned immunosuppression
Hadamitzky, M., Bösche, K., Wirth, T., Buck, B., Beetz, O., Christians, U., Schniedewind, B., Lückemann, L., Güntürkün, O., Engler, H., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.009 · Cited by 38
“…learned immune response: employing these learning paradigms in clinical situations as supportive therapy together with standard pharmacological regimen with the aim to maximize the therapeutic outcome for the patient’s benefit (Doering and Rief, 2012; Enck et al., 2013; Schedlowski et al., 2015).”
BackgroundSelf-citationPlacebo Effects: Historical and Modern Evaluation
Finniss, D. G. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.010 · Cited by 38
Galindo, M. N., Navarro, J. F., & Cavas, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00849 · Cited by 35
“On the one hand, Pavlovian conditioning connects a substance with therapeutic effect and gustatory, tactile, visual, or contextual cues present in the situation because of repetition; hence these cues cause the same response that the substance does (4, 7).”
BackgroundAtkinson, S. D., Lubaczewski, S. L., Ramaker, S., England, R. D., Wajsbrot, D., Abbas, R., & Findling, R. L. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0099 · Cited by 34
“Factors associated with placebo response and potential strategies for reducing placebo response have been identified and discussed in the published literature (Bridge et al. 2009; Enck et al. 2013; Rief et al. 2016).”
BackgroundUnique aspects of clinical trials of invasive therapies for chronic pain
Cohen, S. P., Wallace, M. S., Rauck, R. L., & Stacey, B. R. (2018) · PAIN Reports · doi:10.1097/pr9.0000000000000687 · Cited by 37
“response is common and some argue that it is enhanced.(11,46,96,107) For clinical trials evaluating these procedures, minimizing the placebo response is one way of increasing assay”
BackgroundKang, H., Miksche, M. S., & Ellingsen, D. (2022) · Pain · doi:10.1097/j.pain.0000000000002753 · Cited by 38
Clayton, A. (2022) · Archives of Sexual Behavior · doi:10.1007/s10508-022-02472-8 · Cited by 38
Understanding and translating the knowledge about placebo effects: the contribution of psychology
Geers, A. L., & Miller, F. G. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000082 · Cited by 40
Placebo Responses on Cardiovascular, Gastrointestinal, and Respiratory Organ Functions
Meißner, K. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_11 · Cited by 40
Effect of placebo groups on blood pressure in hypertension: a meta-analysis of beta-blocker trials
Wilhelm, M., Winkler, A., Rief, W., & Doering, B. K. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.10.009 · Cited by 38
Self-citationHigh-altitude headache: the effects of real vs sham oxygen administration
Benedetti, F., Durando, J., Giudetti, L., Pampallona, A., & Vighetti, S. (2015) · Pain · doi:10.1097/j.pain.0000000000000288 · Cited by 40
Cuppone, D., Pérez, L. J. G., Cardullo, S., Cellini, N., Sarlo, M., Soldatesca, S., Chindamo, S., Madeo, G., & Gallimberti, L. (2021) · Journal of Behavioral Addictions · doi:10.1556/2006.2021.00032 · Cited by 35
“…of view the placebo response may be triggered by various interrelated environmental and psychosocial factors, such as patient ’ s expectations of the bene fi t of a treatment, behavioural conditioning, and the quality of the patient – physician relationship (Enck, Bingel, Schedlowski & Rief, 2013).”
BackgroundWho responds to placebos? Considering the “placebo personality” via a transactional model
Darragh, M., Booth, R. J., & Consedine, N. S. (2014) · Psychology Health & Medicine · doi:10.1080/13548506.2014.936885 · Cited by 38
“…the effect of the therapeutic context (Colloca & Benedetti, 2005), there is a placebo component to traditional (pharmaceutical) treatments (Enck et al., 2013), and there are indications that there are dispositional variables associated with being more responsive to both sham and “real”…”
BackgroundInfluentialContextual effects: how to, and how not to, quantify them
Saueressig, T., Pedder, H., Owen, P. J., & Belavý, D. L. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02152-2 · Cited by 36
“For an in-depth exploration of the mechanisms underlying the contextual effects, refer to Enck et al. [24].”
BackgroundMethodCan a Brief Relaxation Exercise Modulate Placebo or Nocebo Effects in a Visceral Pain Model?
Elsenbruch, S., Roderigo, T., Enck, P., & Benson, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00144 · Cited by 37
“Facilitating placebo while minimizing nocebo effects may contribute to refining treatment approaches to provide patients with improved and more personalized patient care (10, 11).”
Self-citationEmerging clinical trends and perspectives on comorbid patterns of mental disorders in research
Fava, G. A., Tossani, E., Bech, P., Berrocal, C., Chouinard, G., Csillag, C., Wittchen, H., & Rief, W. (2014) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1412 · Cited by 31
“Further, one may wonder, whether the fact that failed or inconclusive drug randomized controlled trials are particularly frequent (Otto and Nierenberg, 2002) is due to lack of consideration of treatment history and comorbidity (Enck et al., 2013; Fava et al., 2013).”
BackgroundSelf-citationSelf-selection vs Randomized Assignment of Treatment for Appendicitis
Writing Group for the CODA Collaborative, Parsons, C. S., Shapiro, N. I., Cooper, R., Tichter, A. M., Fleischman, R. J., Howell, E. C., Kim, D. S., Putnam, B. A., Spence, L. H., et al. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.1554 · Cited by 32
Broelz, E. K., Enck, P., Niess, A. M., Schneeweiß, P., Wolf, S., & Weimer, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-38828-9 · Cited by 36
Self-citationNeural underpinnings of open-label placebo effects in emotional distress
Schaefer, M., Kühnel, A., Schweitzer, F. M., Enge, S., & Gärtner, M. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01501-3 · Cited by 37
“Similar mechanisms are also discussed for emotional placebo responses [15].”
BackgroundBenson, S., Hagen, S., Hoffmann, O., Pasler, A., Bingel, U., Schedlowski, M., Peters, J., Elsenbruch, S., & Frey, U. H. (2019) · Pain · doi:10.1097/j.pain.0000000000001546 · Cited by 36
“It comprised verbal suggestions and sham acupuncture as 2 components that have previously been established in experimental and chronic pain.(15,30,34,42,48) Together, our data suggest that optimizing treatment expectations may offer a promising approach to improve postoperative pain management.”
Self-citationHadamitzky, M., Bösche, K., Engler, A., Schedlowski, M., & Engler, H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.040 · Cited by 34
“For example, associative learning paradigms like this could be employed in clinical situations as supportive therapy together with standard pharmacological regimes, with the goal to maximize the therapeutic outcome for the patient’s benefit (Enck et al., 2008, 2013).”
MethodSelf-citationThe influence of psychological traits and prior experience on treatment expectations
Basedow, L. A., Fischer, A., Benson, S., Bingel, U., Brassen, S., Büchel, C., Engler, H., Mueller, E. M., Schedlowski, M., & Rief, W. (2023) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2023.152431 · Cited by 32
Self-citationGeneralization of learned pain modulation depends on explicit learning
Koban, L., Kusko, D. A., & Wager, T. D. (2017) · Acta Psychologica · doi:10.1016/j.actpsy.2017.09.009 · Cited by 35
Metadata
- Authors
- Enck, P., Bingel, U., Schedlowski, M., & Rief, W.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Essen University Hospital (DE)
- Philipps University of Marburg (DE)
- Corresponding author
- Enck, Paul
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-03
- Volume
- 12
- Issue
- 3
- Pages
- 191-204
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2062838995
- Cited by
- 671
- References
- 168
- Citations by year
- 2026: 32 · 2025: 53 · 2024: 45 · 2023: 50 · 2022: 41 · 2021: 51 · 2020: 58 · 2019: 53 · 2018: 63 · 2017: 54 · 2016: 51 · 2015: 47 · 2014: 50 · 2013: 23
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- placebo response, placebo effect, drug development, clinical trials, patient expectations, learning mechanisms, personalized medicine, genetic susceptibility, drug efficacy
- MeSH terms
- Clinical Trials as Topic, Humans, Physician-Patient Relations, Drug Design, Placebo Effect, Treatment Outcome, Drug Discovery, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.